National HealthCare Co. (NYSE:NHC – Get Free Report) VP Timothy J. Shelly sold 614 shares of the firm’s stock in a transaction dated Friday, December 13th. The stock was sold at an average price of $121.44, for a total value of $74,564.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
National HealthCare Price Performance
NYSE NHC opened at $99.52 on Thursday. The company has a market cap of $1.54 billion, a price-to-earnings ratio of 12.47 and a beta of 0.46. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.80 and a quick ratio of 1.77. The stock’s fifty day moving average price is $119.67 and its 200 day moving average price is $122.24. National HealthCare Co. has a 1 year low of $87.03 and a 1 year high of $138.49.
National HealthCare Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Monday, December 30th will be paid a $0.61 dividend. This represents a $2.44 annualized dividend and a dividend yield of 2.45%. The ex-dividend date of this dividend is Monday, December 30th. National HealthCare’s payout ratio is 30.58%.
Institutional Investors Weigh In On National HealthCare
Analysts Set New Price Targets
Separately, StockNews.com raised shares of National HealthCare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 16th.
Check Out Our Latest Stock Analysis on NHC
National HealthCare Company Profile
National HealthCare Corporation engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities.
See Also
- Five stocks we like better than National HealthCare
- How to buy stock: A step-by-step guide for beginners
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- NYSE Stocks Give Investors a Variety of Quality Options
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- The Significance of Brokerage Rankings in Stock Selection
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for National HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.